Prescribing volume remains the main driver of prescription drug spending

By  

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 305, 2001-01 ,pp. : 2-2

Adis International

Access to resources Recommend Favorite

Spending on prescription drugs for infants, children, adolescents and young adults has increased

By  

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 382, 2002-01 ,pp. : 12-12

Adis International

Access to resources Recommend Favorite

Biochemical Mechanisms of New Molecular Entities (NMEs) Approved by United States FDA During 2001-2004: Mechanisms Leading to Optimal Efficacy and Safety

By  

Current Topics in Medicinal Chemistry, Vol. 6, Iss. 5, 2006-03 ,pp. : 461-478

Bentham Science Publishers

Access to resources Recommend Favorite

A Quantitative Framework and Strategies for Management and Evaluation of Metabolic Drug-Drug Interactions in Oncology Drug Development: New Molecular Entities as Object Drugs

By Venkatakrishnan Karthik  

Clinical Pharmacokinetics, Vol. 49, Iss. 11, 2010-11 ,pp. : 703-727

Adis International

Access to resources Recommend Favorite

Why Drugs Fail - A Study on Side Effects in New Chemical Entities

By  

Current Pharmaceutical Design, Vol. 11, Iss. 27, 2005-10 ,pp. : 3545-3559

Bentham Science Publishers

Access to resources Recommend Favorite